157 related articles for article (PubMed ID: 1080553)
1. Aspects of the biochemical pharmacology of cytembena.
Jackson RC; Taylor GA; Harrap KR
Neoplasma; 1975; 22(3):259-68. PubMed ID: 1080553
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of folate antagonists versus enzymatic folate depletion on folate and thymidine enzymes in cultured mammalian cells.
Chello PL; McQueen CA; DeAngelis LM; Bertino JR
Cancer Treat Rep; 1977 Jul; 61(4):539-48. PubMed ID: 195727
[No Abstract] [Full Text] [Related]
3. Changes of molecular properties associated with the development of resistance against methotrexate in human lymphoblastoid cells.
Niethammer D; Jackson RC
Eur J Cancer (1965); 1975 Dec; 11(12):845-54. PubMed ID: 1243674
[No Abstract] [Full Text] [Related]
4. Role for cytosolic folate-binding proteins in the compartmentation of endogenous tetrahydrofolates and the 5-formyl tetrahydrofolate-mediated enhancement of 5-fluoro-2'-deoxyuridine antitumor activity in vitro.
Matherly LH; Czajkowski CA; Muench SP; Psiakis JT
Cancer Res; 1990 Jun; 50(11):3262-9. PubMed ID: 2139802
[TBL] [Abstract][Full Text] [Related]
5. Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM.
Pizzorno G; Moroson BA; Cashmore AR; Russello O; Mayer JR; Galivan J; Bunni MA; Priest DG; Beardsley GP
Cancer Res; 1995 Feb; 55(3):566-73. PubMed ID: 7834626
[TBL] [Abstract][Full Text] [Related]
6. The reaction of Cytembena with cellular thiol compounds.
Jackson RC; Taylor GA; Harrap KR
Neoplasma; 1976; 23(4):355-62. PubMed ID: 1036760
[TBL] [Abstract][Full Text] [Related]
7. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ
Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838
[TBL] [Abstract][Full Text] [Related]
8. Properties of tetrahydropteroylpentaglutamate bound to 10-formyltetrahydrofolate dehydrogenase.
Kim DW; Huang T; Schirch D; Schirch V
Biochemistry; 1996 Dec; 35(49):15772-83. PubMed ID: 8961940
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and cellular pharmacology of 1843U89, a novel benzoquinazoline inhibitor of thymidylate synthase.
Duch DS; Banks S; Dev IK; Dickerson SH; Ferone R; Heath LS; Humphreys J; Knick V; Pendergast W; Singer S
Cancer Res; 1993 Feb; 53(4):810-8. PubMed ID: 8428362
[TBL] [Abstract][Full Text] [Related]
10. Factors determining cell sensitivity to methotrexate: studies of folate and deoxyribonucleoside triphosphate pools in five mammalian cell lines.
Tattersall MH; Jackson RC; Jackson ST; Harrap KR
Eur J Cancer (1965); 1974 Dec; 10(12):819-26. PubMed ID: 4549304
[No Abstract] [Full Text] [Related]
11. Relationship of reduced folate changes to inhibition of DNA synthesis induced by methotrexate in L1210 cells in vivo.
Priest DG; Bunni M; Sirotnak FM
Cancer Res; 1989 Aug; 49(15):4204-9. PubMed ID: 2743307
[TBL] [Abstract][Full Text] [Related]
12. The intracellular concentration dependence of antifolate inhibition of DNA synthesis in L1210 leukemia cells.
Sirotnak FM; Donsbach RC
Cancer Res; 1974 Dec; 34(12):332-40. PubMed ID: 4429954
[No Abstract] [Full Text] [Related]
13. Role of methylenetetrahydrofolate depletion in methotrexate-mediated intracellular thymidylate synthesis inhibition in cultured L1210 cells.
Bunni M; Doig MT; Donato H; Kesavan V; Priest DG
Cancer Res; 1988 Jun; 48(12):3398-404. PubMed ID: 3370638
[TBL] [Abstract][Full Text] [Related]
14. Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists.
Chello PL; McQueen CA; DeAngelis LM; Bertino JR
Cancer Res; 1976 Jul; 36(7 PT 1):2442-9. PubMed ID: 1277151
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a localized conversion of endogenous tetrahydrofolate cofactors to dihydrofolate as an important element in antifolate action in murine leukemia cells.
Matherly LH; Muench SP
Biochem Pharmacol; 1990 Jun; 39(12):2005-14. PubMed ID: 2141258
[TBL] [Abstract][Full Text] [Related]
16. Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier system.
Fry DW; Besserer JA; Boritzki TJ
Cancer Res; 1984 Aug; 44(8):3366-70. PubMed ID: 6547636
[TBL] [Abstract][Full Text] [Related]
17. Effects of folate deficiency on some hepatic enzymes of folate metabolism in the oestrogen-treated immature female chick (domestic fowl).
Burns RA; Jackson N
Biochem Soc Trans; 1976; 4(5):914-7. PubMed ID: 1001792
[No Abstract] [Full Text] [Related]
18. Interaction of thymidylate synthetase and dihydrofolate reductase enzymes in vitro and in vivo.
Kawai M; Hillcoat BL
Cancer Res; 1974 Jul; 34(7):1619-26. PubMed ID: 4833915
[No Abstract] [Full Text] [Related]
19. Membrane transport of natural folates and antifolate compounds in murine L1210 leukemia cells: role of carrier- and receptor-mediated transport systems.
Westerhof GR; Jansen G; van Emmerik N; Kathmann I; Rijksen G; Jackman AL; Schornagel JH
Cancer Res; 1991 Oct; 51(20):5507-13. PubMed ID: 1655252
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and pharmacologic basis for potentiation of 5-fluorouracil action by leucovorin.
Rustum YM; Trave F; Zakrzewski SF; Petrelli N; Herrera L; Mittelman A; Arbuck SG; Creaven PJ
NCI Monogr; 1987; (5):165-70. PubMed ID: 2448653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
